Nasometry devices are medical instruments used for nasal airflow measurements to diagnose sinus disorders. These devices help to assess nasal obstruction, which is a common symptom of sinusitis, rhinitis and other sinus related conditions. Nasometry examines nasal breathing patterns by measuring nasalance scores, which indicate nasal airway functionality and determine the degree of nasal obstruction. Key advantages of nasometry include non-invasiveness, ability to evaluate nasal patency objectively and applicability for both adults and children. Rising prevalence of chronic sinusitis and allergic rhinitis has increased the demand for effective diagnostic tools like nasometry devices.
The Global Nasometry Devices Market is estimated to be valued at US$ 250.9 Mn in 2024 and is expected to exhibit a CAGR of 4.3% over the forecast period 2024 To 2031.
Key Takeaways
Key players operating in the Nasometry Devices are GM Instruments Ltd., Rose Medical Solutions Ltd., PENTAX Medical, Otopront GmbH, BioRESEARCH Associates, Inc., Medtronic, Homoth Medizinelektronik, Recorders Medicare Systems Private Limited, Atmos MedizinTechnik GmbH & Co.KG, Collin Medical, Euroclinic MediCare Solutions, SWORD MEDICAL LTD., Glottal Enterprises Incorporated, and Vivos Therapeutics Inc.
The rising awareness regarding sinus disorders and associated chronic conditions has opened various opportunities for advanced diagnostic technologies like nasometry. Further, growing geriatric population prone to sinus problems will continue driving the Nasometry Devices Market Growth.
Key players are expanding their geographical presence in emerging economies through distribution agreements, mergers and acquisitions. For instance, Medtronic recently acquired Otopront GmbH to enhance its portfolio of ENT diagnostic devices in the European market. Rising medical tourism in Asia Pacific countries has attracted several global players to establish manufacturing facilities in the region.
Market Drivers:
– Growing prevalence of chronic sinusitis worldwide due to increasing environmental pollution and sedentary lifestyles. As per statistical estimates, around 1 in 7 adults suffer from sinusitis annually in the US.
– Rising healthcare expenditure in developing countries enabling greater affordability and adoption of advanced diagnostic technologies.
Market Restraints:
– Limited insurance coverage and reimbursements for nasometry procedure in many countries restricting its wide acceptance.
– Availability of alternative cost-effective tests for nasal assessment can hamper nasometry devices demand to some extent.
Segment Analysis
Nasometry devices market comprised of sub segment such as rhinomanometer and acoustic rhinometry. Rhinomanometry held dominant share of over 60% in 2024 due higher adoption by ENT specialist for assessment of nasal patency. Rhinomanometer provides objective, non-invasive assessment of nasal resistance. Acoustic rhinometry segment is expected to witness highest growth during forecast period due growing awareness regarding subtle anatomic details of nasal cavities. Acoustic rhinometry enable visualization and quantitative measurement of intranasal cavity to identify abnormalities at early stage.
Global Analysis
In terms of regional analysis, North America dominated the global nasometry devices market in 2024 and anticipated to remain most lucrative region during forecast period. Higher prevalence of nasal disorders such as chronic rhinosinusitis and nasal polyps coupled with availability of advanced healthcare infrastructure in the region driving market growth. Europe is second largest market for nasometry devices maintaining significant growth rate owing to improving healthcare expenditure and rising number of ENT specialist in western European countries. Asia Pacific projected exhibit fastest growth rate during forecast period majorly due expanding medical tourism industry in developing countries like India and China offering cost effective treatment.
Get more insights on This Topic- Nasometry Devices Market